Amniotic fluid (AF) has become an interesting source of fetal stem cells. However, AF
contains heterogeneous and multiple, partially differentiated cell types. After isolation from …

In addition to the placenta, umbilical cord and amniotic fluid, the amniotic membrane is
emerging as an immensely valuable and easily accessible source of stem and progenitor …

Cells derived from the amniotic foetal membrane of human term placenta have drawn
particular attention mainly for their plasticity and immunological properties, which render …

Human amniotic mesenchymal cells (hAMTCs) possess interesting immunomodulatory
properties, making them attractive candidates for regenerative medicine applications …

Aim The study was conducted to investigate secretory activity and define the paracrine
potential of mesenchymal stem cells from human umbilical cord and amniotic membrane …

The human umbilical cord (UC) and placenta are non-invasive, primitive and abundant
sources of mesenchymal stromal cells (MSCs) that have increasingly gained attention …

PURPOSE: The surgical treatment of congenital anomalies using tissues engineered from
amniotic fluid-derived mesenchymal cells has been validated experimentally. As a …

The amniotic membrane (AM) and amniotic fluid (AF) have a long history of use in surgical
and prenatal diagnostic applications, respectively. In addition, the discovery of cell …

Abstract Introduction Mesenchymal stem cells (MSCs) represent a heterogeneous cell
population that is promising for regenerative medicine. The present study was designed to …

Recent evidence shows that amniotic fluid (AF) contains multiple cell types derived from the
developing fetus, and may represent a novel source of stem cells for cell therapy. In this …